FIN

China Tightens Control Over AI Models as Tech Giants Halt Overseas Features China is reportedly considering restrictions on overseas access to its leading artificial intelligence (AI) models, according to multiple …

The United Kingdom faces a long-term fiscal challenge that will require significant tax increases or spending cuts to stabilize national debt, according to the Office for Budget Responsibility (OBR). In …

Syngenta’s Strategic Pivot: Embracing Chinese Ownership Amid Global Market Pressures Syngenta Group, the Swiss-based agricultural giant owned by state-run ChemChina, is increasingly leaning into its Chinese identity to navigate complex …

Federal Reserve Chair Jerome Powell and other top U.S. monetary policymakers continue to signal a data-dependent approach to interest rate adjustments, refraining from committing to specific timelines for cuts despite …

Nigeria’s government faces increasing scrutiny over its fiscal transparency, as International Monetary Fund (IMF) officials recently highlighted that approximately 2% of the nation’s gross domestic product (GDP) remains unreported in …

Medicare Expands Coverage for GLP-1 Weight Loss Drugs Amid Rising Demand Medicare will begin covering GLP-1 (glucagon-like peptide-1) weight loss medications for eligible seniors starting in 2024, with a $50 …

Lloyds Survey Reveals Downturn in UK Business Confidence UK business morale has declined as companies grapple with persistent cost pressures and economic uncertainty, according to a report by Lloyds Banking …

PBOC Debuts Overnight Reverse Repo Rate at 1.25% to Fine-Tune Liquidity The People’s Bank of China (PBOC) launched a new overnight reverse repo facility with an initial rate of 1.25%, …

Rising Energy Costs Drive Solar Adoption Across Southeast Asia The Philippines and Thailand are experiencing a significant surge in rooftop solar installations as households and businesses seek to mitigate the …

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the revocation of the marketing authorization for Tavneos (avacopan), an Amgen-manufactured treatment for severe active …